- Không có dữ liệu
Tiếng Việt
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Recently, OSRAM, a well-known global automotive lighting brand, announced the launch of its modified new laser headlights - the Yutianba laser headlights. Laser headlights were once regarded by many car companies as the "successor" of LED headlights, and German century old automotive lighting expert Osram is precisely the pioneer of laser light sources for automotive headlights. Since the 2014 BMW...
The use of industrial lasers has become a viable option for many manufacturing processes. It enables workers to simplify steps, improve precision and benefit from the benefits associated with output. Decision makers will get the best results when they consider the specific possibilities of using lasers in manufacturing. Here are some options.Improved cleaning and texturing methodsMany man...
Recently, Professor Tsumoru Shintake from Okinawa University of Science and Technology (OIST) proposed a revolutionary extreme ultraviolet (EUV) lithography technology that not only surpasses the boundaries of existing semiconductor manufacturing, but also heralds a new chapter in the industry's future.This innovation significantly improves stability and maintainability, as its simplified design o...
The optical properties of photonic crystals are closely related to their lattice constants, which are usually required to be in the same order of magnitude as the operating wavelength. In a crystal material, the photonic crystal structure is formed by the periodic arrangement in space of units whose dielectric constant is different from that of the crystal itself, and whose lattice constant depend...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...